ClinConnect ClinConnect Logo
Search / Trial NCT01249599

Stress-induced Vascular Dysfunction: Evaluation of Endothelial Function in a Cohort of Patients With Takotsubo Syndrome

Launched by UNIVERSITY OF ZURICH · Nov 29, 2010

Trial Information

Current as of May 28, 2025

Completed

Keywords

Takotsubo Syndrome Apical Balooning Syndrome Stress Cardiomyopathy Endothelial Function Sympathetic Nervous Activity Platelet Adhesion Arterial Compliance

ClinConnect Summary

The aim of this prospective single-center study is to evaluate endothelial function, arterial compliance, sympathetic nervous activity at rest and after mental and physical stress, carotid atherosclerosis, oxidative stress parameters, quality of life and platelet adhesion in patients with Takotsubo Syndrome (apical ballooning syndrome/broken heart syndrome) and age-matched controls.

Gender

ALL

Eligibility criteria

  • Inclusion criteria: We plan to include male or female subjects, age 18-80 with a diagnosis of Takotsubo Syndrome (according to standard clinical criteria\[Strony, J., et al., Analysis of shear stress and hemodynamic factors in a model of coronary artery stenosis and thrombosis. Am J Physiol, 1993. 265(5 Pt 2): p. H1787-96.\]) in the last 10 years.
  • Moreover, patients matched to the Takotsubo patients for age and cardiovascular risk factors will be included in the control group.
  • All patients will signed an written informed consent
  • Exclusion criteria:
  • Long acting nitrates, or PDE-5-Hemmer
  • Alcohol or drug abuse,
  • Malignancy (unless healed or remission \> 5 years)
  • Disease with systemic inflammation (e.g. rheumatoid arthritis, M. Crohn)
  • Pulmonary Hypertension
  • Participation in another study within the last month

About University Of Zurich

The University of Zurich, a leading institution in research and education, is dedicated to advancing medical knowledge and improving patient care through innovative clinical trials. With a robust framework for conducting high-quality research, the university collaborates with multidisciplinary teams of experts to explore cutting-edge therapeutic approaches and interventions. Its commitment to ethical standards and patient safety ensures that all clinical trials are conducted with the utmost integrity, aiming to contribute valuable insights to the medical community and enhance health outcomes globally.

Locations

Zurich, Zh, Switzerland

Patients applied

0 patients applied

Trial Officials

Georg Noll, Prof MD

Principal Investigator

University Hospital Zurich, Division of Cardiology

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported

Similar Trials